Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure

PURPOSE: Diuretics are the primary treatment for the management of chronic heart failure (HF) symptoms and for the improvement of acute HF symptoms. The rate of delivery to the site of action has been suggested to affect diuretic pharmacodynamics. The main objective of this clinical trial was to exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballester, Maria Rosa, Roig, Eulàlia, Gich, Ignasi, Puntes, Montse, Delgadillo, Joaquín, Santos, Benjamín, Antonijoan, Rosa Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532344/
https://www.ncbi.nlm.nih.gov/pubmed/26273191
http://dx.doi.org/10.2147/DDDT.S86300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532344/
https://www.ncbi.nlm.nih.gov/pubmed/26273191
http://dx.doi.org/10.2147/DDDT.S86300

Ejemplares similares